BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12099324)

  • 1. Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death.
    Goldstein S
    Am J Manag Care; 2002 Jun; 8(9 Suppl):18-24. PubMed ID: 12099324
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta blockers as cardioprotective agents: Part I--Insights into mechanisms of action.
    Frishman WH
    Am J Manag Care; 2002 Jun; 8(9 Suppl):13-7. PubMed ID: 12099323
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-blocker-induced heart rate lowering, cardioprotection, and hypertension.
    Khan SS
    J Am Coll Cardiol; 2009 Jun; 53(22):2104-5; author reply 2106-7. PubMed ID: 19477368
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockers for preventing sudden cardiac death.
    Giles TD; Basile JN
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic modulation of autonomic tone: implications for the diabetic patient.
    Aronson D
    Diabetologia; 1997 Apr; 40(4):476-81. PubMed ID: 9112027
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blockers: cardiac jacks of all trades. Uses for beta blockers range from lowering blood pressure to improving heart failure.
    Harv Heart Lett; 2011 Dec; 22(4):4-5. PubMed ID: 22319827
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are beta blockers effective first-line treatments for hypertension?
    Cayley WE
    Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
    de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death.
    Kaplan NM
    Am J Cardiol; 1997 Nov; 80(9B):20J-22J. PubMed ID: 9375945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
    Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
    J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benefits of antihypertensive treatment. How much damage does it really prevent?].
    Holzgreve H
    MMW Fortschr Med; 2006 Apr; 148(14):47, 49-50. PubMed ID: 16669282
    [No Abstract]   [Full Text] [Related]  

  • 15. Might losartan reduce sudden cardiac death in diabetic patients with hypertension?
    Aronow WS
    Lancet; 2003 Aug; 362(9384):591-2. PubMed ID: 12944056
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension and cardiac arrhythmias. Beta blockers frequently help, but not always].
    Motz W; Stockinger J
    MMW Fortschr Med; 1999 Dec; 141(51-52):35-6. PubMed ID: 10949623
    [No Abstract]   [Full Text] [Related]  

  • 19. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers and hypertension.
    Cruickshank JM
    J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.